Stop by at SFN to see Impel’s Device in Poster Presentations
Be sure to check out these poster presentations featuring the POD devices at SFN 2015 in Chicago this week!
Monday, October 19, 2015
1:00 pm – 5:00 pm
Hall A | Program#/Poster#: 395.18/D39
L Tan, Ph.D., Salk Institute
Intranasal administration of a small molecule...
ST. PAUL, MN. and Seattle, WA – 3M Drug Delivery Systems (3M) and Impel NeuroPharma Inc (Impel) today announced a strategic alliance aimed at advancing Impel’s revolutionary Precision Olfactory Delivery (POD) technology for the enhanced Central Nervous System (CNS) delivery of drug products. The alliance further solidifies 3M’s presence as...
SEATTLE, Wash., October 30, 2014 – Impel NeuroPharma is pleased toannounce that H. Stewart Parker, a prominent leader in Seattle’s Biotechnology community, has joined Impel’s Board of Directors.
Most recently, Parker was the CEO of the Seattle-based Infectious Disease Research Institute (IDRI), a nonprofit global health research institute developing diagnostics, vaccines,...
March 24, 2014 – A nasal spray that delivers a new type of depression treatment holds promise as a potential alternative therapeutic approach, research from the Centre for Addiction and Mental Health (CAMH) shows.
The study, led by CAMH’s Dr. Fang Liu, is published online in Neuropsychopharmacology.
In a previous study published in...